Sofia Fund participates in recently closed $8M financing round announced by existing portfolio company, Oculogica. This round of funding will support further commercial distribution of the EyeBOX at Level I, II and III trauma centers nationwide, including additional units in use with the U.S.…
Sofia Fund partner and long-time investor in women-led tech businesses, Joy Lindsay, reflects on Minnesota’s 2019 fundraising record.
“While the majority of the capital goes to the Bay Area, New York and Boston, several Minnesota companies raised significant amounts in 2019,” Joy Lindsay, managing partner at Minneapolis-based Sofia Fund, told Minne Inno.…
Pittsburgh, PA, November 20, 2019 (GLOBE NEWSWIRE) – Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the protection and restoration of synaptic function in Alzheimer’s disease and other neurodegenerative disorders, today announced that President & CEO Kenneth I.…
The American Medical Association (AMA) has confirmed the addition of a new Category 3 CPT Code, 0X17T, Eye movement analysis test without spatial calibration, allowing clinicians to appropriately report the services related exclusively to the Oculogica EyeBOX® exam.
Read the entire press release here:
https://www.biospace.com/article/releases/oculogica-announces-new-category-3-cpt-code-created-by-american-medical-association/…
Third blog in a series by Lisa Crump, founder of Cairn Ventures and Managing Partner, Sofia Fund. View Part I here. View Part II here.
Cash is King Pharaoh*
Conservation of cash is key to building a strong business.…
New Sofia Fund Kansas City partner Laura McCoolidge, on convertible notes
https://www.startlandnews.com/2019/09/fundraising-for-real-convertible-notes/…
Portfolio company CogRX gains patent coverage in Japan and China for Elayta, Cognition’s lead drug for treatment of mild to moderate Alzheimer’s disease.
Sofia Fund portfolio company, Joylux, announces they have raised more than $9M exclusively through prominent angel investors and angel groups including the Sofia Fund and has expanded their Advisory Board by adding Dr. Michael Friedman, former FDA Commissioner.
Sofia Fund is a national go-to resource for what’s happening in the Midwest startup community. See ABC News story here.…